Letrozole and abemaciclib in estrogen receptor–positive recurrent endometrial cancer
Physician's Weekly,
1. Almost half of patients (47%) had either an objective response or had progression free survival for at least 6 months after…
1. Almost half of patients (47%) had either an objective response or had progression free survival for at least 6 months after…
As you have probably noticed, there’s been a major shift in the focus of next-gen sequencing over the past couple of years.
UMMS cancer experts say findings from two new studies show that cancer may be better defined by its genetics than the organ in…
Christopher Lima of MSKCC was selected to join the Howard Hughes Medical Institute Investigator Program. Gopa Iyer of MSKCC…
By Ellie Hammer…
In Nature this week: omic analysis of endometrial cancers, 80S ribosome structures, and more. read more
April 2 is World Autism Awareness Day. I've already begun the day by engaging in a twitter exchange with a mother of three…